BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$0.94−0.05 (-5.27%)
Close on Nov 18, 2026Market cap $7.11MP/E –Yield –
BioVie pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for BioVie
BioVie has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?